Elanco Animal Health Inc

Company Profile

Elanco Animal Health Inc had its IPO on 2020-01-23 under the ticker symbol ELAT.

The company operates in the sector and industry. Elanco Animal Health Inc has a staff strength of 0 employees.

Stock update

Shares of Elanco Animal Health Inc opened at $20.37 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $19.13 - $21.51, and closed at $21.32.

This is a +1.04% increase from the previous day's closing price.

A total volume of 1,123,314 shares were traded at the close of the day’s session.

In the last one week, shares of Elanco Animal Health Inc have increased by +3.55%.

Elanco Animal Health Inc's Key Ratios

Elanco Animal Health Inc has a market cap of $0, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months Elanco Animal Health Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures Elanco Animal Health Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Elanco Animal Health Inc’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q4, Elanco Animal Health Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Elanco Animal Health Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Elanco Animal Health Inc’s profitability.

Elanco Animal Health Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

Elanco Animal Health Inc stock pays annual dividends of $ per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$15.49 billion

Total Liabilities

$1.70 billion

Operating Cash Flow

$0

Capital Expenditure

$79 million

Dividend Payout Ratio

0%

Elanco Animal Health Inc ended 2024 with $15.49 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $15.49 billion while shareholder equity stood at $7.29 billion.

Elanco Animal Health Inc ended 2024 with $0 in deferred long-term liabilities, $1.70 billion in other current liabilities, in common stock, $-1057000000.00 in retained earnings and $5.99 billion in goodwill. Its cash balance stood at $345.00 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $5.45 billion.

Elanco Animal Health Inc’s total current assets stands at $3.28 billion while long-term investments were $0 and short-term investments were $0. Its net receivables were $797.00 million compared to accounts payable of $390.00 million and inventory worth $1.54 billion.

In 2024, Elanco Animal Health Inc's operating cash flow was $0 while its capital expenditure stood at $79 million.

Comparatively, Elanco Animal Health Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$21.32

52-Week High

$35.8287

52-Week Low

$17.4511

Analyst Target Price

$

Elanco Animal Health Inc stock is currently trading at $21.32 per share. It touched a 52-week high of $35.8287 and a 52-week low of $35.8287. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $19.68 and 200-day moving average was $25.76 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.